medigraphic.com
Academia Mexicana de Neurología, A.C.

2009, Number 3

<< Back Next >>

Rev Mex Neuroci 2009; 10 (3)

Rabies: Viral infection of the central nervous system

Llamas LL, Orozco PE

Language: Spanish
References: 79
Page: 212-219
PDF size: 144.09 Kb.


ABSTRACT

Since ancient rabies has been described and classified, first as an action involving supernatural forces and then as a virulent disease transmitted by contact with infected animals, especially dogs. Gradually, the study of symptoms resulted in a diagnosis and possibly treatment emerged, including those due to Louis Pasteur (1885) and Dr. Eduardo Liceaga (1887), who issued the rabies vaccine based on the work of Pasteur. From the epidemiological point of view, rabies is classified as urban and wild, including the dog as the main transmitter agent in urban alternative and bat, coyote and fox in the wild one. After infection, the subsequent periods are: incubation, prodromal, neurological, coma and death. For these stages, treatment consists of prophylaxis and vaccination. Aspects that are reviewed in this paper.


REFERENCES

  1. Hildreth E. Prevention of rabies. Ann Int Med 1963; 58: 883-97.

  2. Hankins DG, Rosekrans JA. Overview, prevention, and treatment of rabies. Mayo Clinic Proc 2004; 79: 671-6.

  3. Jiménez A, Torres JL, López S. Situación epidemiológica de la rabia a nivel mundial y en México. Enfermedades infecciosas y microbiología 1996; 16(1): 29-38.

  4. Navarro AMV, Bustamantes NJ, Santo AS. Situación actual y control de la rabia en el Perú. Rev Peru Med Exp Salud Pública 2007; 24(1): 46-50.

  5. Campillo CS, Cota-Mujica C. La rabia humana en México. Gac Med Mex 1980; 116: 517-23.

  6. Gómez JA. La rabia: ¿una historia de nunca acabar? Neurología 2006; 21(4): 169-70.

  7. Carrada TB. Visión nueva de un mal milenario. Rev Mex Patol Clin 2004; 51(3): 153-66.

  8. Corey L. Rabia, enfermedades por Rabdovirus y por agentes del tipo Marburg. En: Harrison: Principios de Medicina interna. 13a Ed. Interamericana; 1994, Cap. 158, p. 966-70.

  9. Mann J. Immunization against rabies pre-and postexposure. En: Winkler WG (ed.). Rabies concepts for medical professionals. Miami: Merieux, Inst; 1984, Cap.7, p. 51-8.

  10. Atanasio P, Gamet A. Rabies. En: Vinken PJ, Bruyn GW (eds.). Handbook of Clinical Neurology. North Holland, Amsterdam; 1978, Vol. 3, p. 235-71.

  11. Valdéz A. Diagnóstico clínico de la rabia en el perro. Salud Pub Mex 1974; 16: 375-7.

  12. Higuera F. Aspectos generales de la rabia en México. Salud Pub Mex 1974; 16: 379-83.

  13. Kaplan M. Epidemiology of rabies. Nature 1969; 221: 421-5.

  14. Haider S. Rabies: old disease, new challenges. CMAJ 2008; 178(5): 562-3.

  15. Hattwick M, Rubin R. Postexposure rabies prophylaxis with human rabies immune globulin. JAMA 1974; 227: 407-10.

  16. McDermid RC, Saxinger L, et al. Human rabies encephalitis following bat exposure: failure of therapeutic coma. CMAJ 2008; 178(5): 557-61.

  17. Epidemiological Bulletin/PAHO 2000; Vol. 21, No. 3.

  18. http://siepi.panaftosa.org.br/Painel.aspx

  19. Houff S, Burton R. Human to human transmission of rabies virus by corneal transplant. New Engl J Med 1979; 300: 603-4.

  20. Conomy J, Leibovitz A. Airbone rabies encephalitis demonstration of rabies virus in human central nervous system. Neurology 1977; 27: 57-69.

  21. Escobar A, Ramírez R, Hernández-Pagaza R, Rivera L. Manifestaciones clínicas y neropatológicas de la rabia. Estudio de cinco casos. Gac Med Mex 1980; 116: 523-8.

  22. Fox S. New form of rabies. Infect Med 1997; 14(8): 293, 612.

  23. Murphy F. The rabies virus and pathogenesis of the disease. En: Winkler WG (ed.). Rabies concepts for Medical Professionals. Miami: Mereiux, Inst; 1984, Cap. 2, p. 11-6.

  24. Atanasiu P. El virus de la rabia. Salud Pub Mex 1974; 16: 345-50.

  25. Miller A, Nathanson N. Rabies: Recent advances in pathogenesis and control. Ann Neurol 1977; 2: 511-9.

  26. Lents T, Burrage T. Is the acetylcholine receptor a rabies virus receptor? Science 1982; 215: 182-4.

  27. Weiner L, Fleming J. Viral infections of the nervous system. J Neurosurg 1984; 61: 207-24.

  28. Ross E, Armentrout S. Myocarditis associated with rabies. New Engl J Med 1962; 266: 1087-9.

  29. Fenge P, Postic B. Protection of Rabbits against experimental rabies by poly-I-Poly C. Nature 1970; 226: 171-2.

  30. Maton P, Pollard J. Human rabies encephalomyelitis. Br Med J 1976; 1: 1038-40.

  31. Johnson R. Viral infections of the nervous system. N.Y.: Raven Press; 1982, Cap.7, p. 159-68.

  32. Macrae A. Rabies. Br Med J 1973; 1: 604-6.

  33. Hummeler K, Koprowski H. Investigating the rabies virus. Nature 1969; 221: 418-21.

  34. De Brito T, Araujo M. Ultrastructure of de Negri Body in human rabies. J Neurol Sci 1973; 20: 363-72.

  35. García-Tamayo J, Avila-Mayor A. Rabies virus neuronitis in humans. Arch Path 1972; 94: 11-5.

  36. Rengell F. Envío de especímenes al laboratorio y técnicas de exámenes para el virus de la rabia. Salud Pub Mex 1974; 16: 385-94.

  37. Adams JH. Virus diseases of the nervous system. En: Blackwood W, Corsellis JAN (eds.). Greenfield’s Neuropathology. London: Arnold; 1976, Chapt. 8, p. 308-10.

  38. Johnson K, Swovenland P. Rabies. En: Neurologic Clinics. Philadelphia, Pa.: WB Saunders; 1984, Vol. 2, p. 255-65.

  39. Hattwick M, Weiss T. Recovery from rabies. Ann Int Med 1972; 76: 931-42.

  40. Warrell D, Davidson N. Pathophysiologic studies in human rabies. Am J Med 1976; 60: 180-90.

  41. Bernard KW. Clinical rabies in humans. En: Winkler WG (ed.). Rabies concepts for medical professionals. Miami: Merieux Institute; 1984, Cap. 5, p. 45-50.

  42. Wilson J. Presenting features and diagnosis of rabies. Lancet 1975; 2: 1139-40.

  43. Turner G. Human diploide cells strain rabies vaccine. Lancet 1976; 1: 1379-81.

  44. Derakshan I. Light-microscopical diagnosis of rabies. Lancet 1978; 1: 302-3.

  45. Johnson K, Swoveland P. Diagnosis of rabies by immunofluorescence in trypsin-treated histologic sections. JAMA 1980; 244: 41-3.

  46. Fekadu M, Smith J. Laboratory diagnosis of rabies. En: Winkler WG (ed.). Rabies concepts for medical professionals. Miami: Merieux, Inst; 1984, Cap. 5, p. 37-43.

  47. Bryceson A, Greenwood B. Demonstration during life or rabies antigen in humans. J Infect Dis 1975; 131: 71-4.

  48. Trimarchi C. Rabies diagnosis and laboratory science. NYS Department of Health, Rabies Laboratory.

  49. Fenichel G. Neurological complications of immunization. Ann Neurol 1982; 12: 119-28.

  50. Cohen S, Gardner S. A case of rabies in man: some problems in diagnosis and management. Br Med J 1976; 1(6017): 1041-2.

  51. Corey L, Hattwickm M. Treatment of persons exposed to Rabies. JAMA 1975; 232: 272-6.

  52. Geyer R, Sastryl L. Human rabies Montana and Washington, 1997, Centers for Disease Control. MMWR 1997; 46(33): 770.

  53. http://www.paho.org/English/HCP/HCV/ZNS/rabia.htm

  54. Doege T, Northrop R. Evidence for in apparent rabies infection. Lancet 1974; 2: 826-9.

  55. Appedbaum E, Greenberg M. Neurological complications following antirabies vaccination. JAMA 1953; 151: 188-91.

  56. Lombardo L. Complicaciones de la vacuna antirrábica. Gac Med Mex 1980; 116: 528-31.

  57. Fuenzalida E. Consideraciones sobre la vacuna en cerebro de ratón lactante. Salud Pub Mex 1954; 16: 443-50.

  58. Heed J. Inmunización humana con vacuna antirrábica de cerebro de ratón lactante. Salud Pub Mex 1974; 16: 469-80.

  59. Escobar A, Ledesma de Dauzón F, Romero C. Meningoencefalomielitis por vacunación antirrrábica con vacuna preparada en el cerebro de ratón lactante. Gac Med Mex 1979; 115: 363-8.

  60. Ajjan N, Sudebot J. Intradermal immunization with rabies vaccine. JAMA 1980; 244: 2528-31.

  61. Garner W, Jones D. Problems associated with rabies preexposure prophylaxis. JAMA 1976; 235: 1131-2.

  62. Rubin R, Hattwick M. Adverse reactions to duck embryo rabies vaccine. Ann Int Med 1973; 78: 643-9.

  63. Atanasiu P. Consideraciones sobre los nuevos tipos de vacunas antirrábicas. Salud Pub Mex 1974; 16: 437-41.

  64. Bahmanyar M, Fayaz A. Successful protection of humans exposed to rabies infection. JAMA 1976; 236: 2751-4.

  65. Turner G, Aoki F. Immunogenicity and acceptability of a human diploidcell culture rabies vaccine in volunteers. Lancet 1975; 1: 660-2.

  66. Atanasio P, Fuenzalida E. El suero antirrábico. Salud Pub Mex 1974; 16: 465-7.

  67. Anderson L, Wuinkder W. Profilaxis for persons in contact with patients. New Engl J Med 1980; 302: 967-8.

  68. Tierkel E, Sikes K. Preexposure prophylaxis against rabies. JAMA 1967; 201: 91-4.

  69. Willoughby RE Jr, Tieves KS, et al. Survival after treatment of Rabies with induction of Coma. NEJM 352(24): 2508-14.

  70. Gode G, Raju A. Intensive care in rabies therapy. Lancet 1976; 2: 6-8.

  71. Jáuregui-Álvarez P. Quimioterapia del virus de la rabia en cultivos de tejidos. Gac Med Mex 1982; 118: 379-87.

  72. Atanasiu P. Patogenia de la rabia. Salud Pub Mex 1974; 16: 357-60.

  73. Báez M. La intervención de la vacunación antirrábica, obra cumbre de Pasteur. Salud Pub Mex 1973; 16: 337-44.

  74. Cohen C, Sartorius B, Sabeta C, Zulu G, Paweska J, Mogoswane M, et al. Epidemiology and molecular virus characterization of reemerging rabies, South Africa. Emerg Infect Dis 2007; 13(12): 1879-86.

  75. Cox H. Rabies: Laboratory diagnosis and postexposed to Rabies. JAMA 1975; 232: 272-6.

  76. Rengell F. Vacunas antirrábicas: aplicación, indicaciones y resultados. Salud Pub Mex 1974; 16: 489-503.

  77. Rengell F. Patología y patogenia de la rabia. Salud Pub Mex 1974; 16: 361-3.

  78. Silvia M. Tratamiento profiláctico después de la exposición a la rabia. Salud Pub Mex 1974; 16: 481-7.

  79. Vionet A, Cerda M. Patología de la rabia. Salud Pub Mex 1974; 16: 365-73.




2020     |     www.medigraphic.com